CTSO

CYTOSORBENTS CORP

CTSO·23283X206·US·Common Stock·Healthcare - Medical Devices-13D/G

CTSO (CYTOSORBENTS CORP) is held by 37 institutional investors as of Q2 2026. Largest holders: Neuberger Berman Group LLC ($740,516), VANGUARD CAPITAL MANAGEMENT LLC ($715,860), BlackRock, Inc. ($234,577). Net institutional sentiment: Mixed.

37
Holders
(3 Elite)
$2.7M
Total Value
48% (31)
Consensus
15 buying - 16 selling
13F: Insider & Congress: Updated regularly
CTSO

Smart Money Verdict

View all
Loading verdict
Held by 37 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 16, 2026 · Activists Feb 13, 2026 · Congress none

InsiderMJMARIANI PETER JBuy $44KJun 15, 2026
ActivistAVAVENIR CORP8.3%Feb 13, 2026
ActivistAVAvenue Venture Opportunities Fund, L.P.1.7%May 28, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2M(+17.0%)$740,5160.0%-91.36%
29
Increased
1.9M(+1.8%)$715,8600.0%-54.57%
17
Decreased
627,211(-19.9%)$234,5770.0%-61.99%
0
Decreased
602,059(-14.9%)$225,2390.0%-90.58%
0
Decreased
499,910(-0.0%)$186,9660.0%-43.75%
0
Increased
316,167(+0.7%)$118,2460.0%-54.82%
15
Unchanged
172,649$64,5710.0%-55.00%
0
Unchanged
159,293$59,5760.0%-66.82%
0
Increased
134,839(+3.4%)$49,9910.0%-88.11%
21
Increased
131,019(+13.7%)$49,0010.0%-57.84%
16
Increased
111,660(+20.7%)$41,7610.0%-93.08%
16
Decreased
107,611(-0.1%)$40,2470.0%-60.07%
0
Decreased
100,020(-0.7%)$37,4070.0%-71.42%
0
Decreased
91,338(-8.8%)$34,1600.0%-48.49%
0
Increased
54,316(+52.7%)$20,3140.0%-36.34%
26
New
52,205$19,5250.0%-3.74%
29
Increased
50,119(+116.2%)$18,7440.0%-38.32%
20
Unchanged
48,000$17,9520.0%-67.18%
0
Decreased
38,686(-1.1%)$14,4680.0%-60.88%
0
Unchanged
28,200$10,5470.0%-64.48%
0

Showing 1-20 of 42

1 / 3
CTSOCTSOCYTOSORBENTS CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used